Efficacy of different cannabinoid compounds on migraine-like responses in female rats
Cephalalgia · 2025
DOI: 10.1177/03331024251386794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, 2025. Verfasst von Fernanda Mariano Ribeiro da Luz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Biological Sciences Sector, Federal University of Parana, Curitiba, Parana, Brazil. Hauptthemen laut MEDLINE: Migraine Disorders, Cannabinoids, Hyperalgesia. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Aim
To investigate the effect of different cannabinoid compounds on the periorbital mechanical allodynia and photosensitivity in acute and chronic migraine models.
Methods
Female Wistar rats were treated systemically with different cannabinoid compounds (cannabidiol, CBD, 30 mg/kg; CBD and cannabigerol, CBD/CBG – 2:1; CBD and 0.3% tetrahydrocannabinol (CBD/THC); or CBD/CBG/THC) followed by injection of calcitonin-gene-related peptide (CGRP) or pituitary adenylate cyclase-activating polypeptide (PACAP) into the trigeminal ganglion to induced immediate periorbital mechanical allodynia and late photosensitivity. The effect of CBD and CBD/THC was also assessed on periorbital mechanical allodynia and photosensitivity in the chronic migraine model induced by repeated nitroglycerin (NTG) injections.
Results
Periorbital mechanical allodynia induced by CGRP was significantly reduced by CBD alone and combined with THC or CBG. CBD/THC was the most effective treatment in this condition since it presented the longer effect (up to three hours) and was the only treatment capable of reducing late photosensitivity associated with CGRP. All four compounds presented antinociceptive effect on acute migraine-like responses induced by PACAP, with CBD alone presenting the longer effect (from 30 minutes up to two hours). Except for CBD/CBG, all compounds also reduced (up to two hours) late photosensitivity associated with PACAP. In the chronic migraine model induced by NTG, CBD reduced periorbital mechanical allodynia on days 5, 7 and 11, while CBD/THC suppressed the development of periorbital allodynia up to day 13 and significantly reduced photosensitivity up to three hours.
Conclusion
Altogether, these results suggest that cannabinoid compounds may represent effective alternatives for the treatment of episodic and chronic migraine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Biological Sciences Sector, Federal University of Parana, Curitiba, Parana, Brazil.
- Neurology Department, Einstein Hospital Israelita, Sao Paulo, Sao Paulo, Brazil.
- Health Meds Laboratories, Rio de Janeiro, Rio de Janeiro, Brazil.
- Isospec Laboratories, Fort Lauderdale, FL, USA.
ORCID-Profile: Fernanda Mariano Ribeiro da Luz, Alexandre Ottoni Kaup, Darciane Favero Baggio, Juliana Geremias Chichorro
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
da Luz, F. M. R., Kaup, A. O., Baggio, D. F., Costa, F. H. R., & Chichorro, J. G. (2025). Efficacy of different cannabinoid compounds on migraine-like responses in female rats. Cephalalgia. https://doi.org/10.1177/03331024251386794
Vancouver
da Luz FMR, Kaup AO, Baggio DF, Costa FHR, Chichorro JG. Efficacy of different cannabinoid compounds on migraine-like responses in female rats. Cephalalgia. 2025. doi:10.1177/03331024251386794
BibTeX
@article{daLuz2025,
author = {da Luz, Fernanda Mariano Ribeiro and Kaup, Alexandre Ottoni and Baggio, Darciane Favero and Costa, Flavio Henrique de Rezende and Chichorro, Juliana Geremias},
title = {Efficacy of different cannabinoid compounds on migraine-like responses in female rats},
journal = {Cephalalgia},
year = {2025},
doi = {10.1177/03331024251386794}
}
EUVIMED